Ozempic can help with blood sugar management, aid with significant weight loss, and perhaps even treat opioid use disorder. Now, there’s one more thing to add to the list: alcohol addiction. New research finds that semaglutide medications like Ozempic and Wegovy may help to lower the risk of alcohol-related issues.

Lähteenvuo notes that while more research is called for, drugs like Ozempic may offer hope to those burdened by addiction, “Our study suggests that besides obesity and diabetes, GLP-1-agonists may also help in the treatment of alcohol and substance use disorders; however, these findings need to be further validated in randomized controlled trials.”

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and osteoarthritis.

GLP-1 drugs have been linked to numerous potential health benefits like treatment of existing conditions including heart disease, Parkinson’s, sleep apnea and addiction.

The blockbuster GLP-1 drug semaglutide (Ozempic, Wegovy) could curb drinking for people battling alcohol use disorder, helping them to avoid crises that require hospitalization, new research shows. Numerous studies had already hinted that semaglutide might act on appetite centers in the brain to suppress the urge to drink,

The blockbuster drugs Ozempic and Wegovy may help people cut back on drinking, new research published Wednesday in JAMA Psychiatry suggests.

The weight loss drugs Ozempic and Wegovy may be beneficial for people struggling with alcohol addiction, a study published Wednesday in JAMA Psychiatry said. The study examined about 228,000 people in Sweden who had alcohol use disorder and Type 2 diabetes.

Ozempic, a diabetes drug that has become a popular drug for weight loss, has another use that could help tens of millions of Americans, researchers say. In a study published in the journal JAMA Psychiatry,